EMN
56
-3
BDX
42
-4
ZTS
54
7
HCA
46
-2
MPC
41
-3
A
39
2
HPE
40
-10
PRU
67
2
BIIB
32
3
ADT
48
-2
GT
69
5
WY
64
4
CPB
37
-3
IP
67
-3
AN
61
-2
V
76
4
EQT
50
-4
NRG
54
-6
EMC
53
-3
T
53
2
EMN
56
-3
BDX
42
-4
ZTS
54
7
HCA
46
-2
MPC
41
-3
A
39
2
HPE
40
-10
PRU
67
2
BIIB
32
3
ADT
48
-2
GT
69
5
WY
64
4
CPB
37
-3
IP
67
-3
AN
61
-2
V
76
4
EQT
50
-4
NRG
54
-6
EMC
53
-3
T
53
2
Financhill
Back

Virtus LifeSci Biotech Clinical Trls ETF Vs. Range Cancer Therapeutics ETF Industry Stock Comparison

Sell
45

BBC
Virtus LifeSci Biotech Clinical Trls ETF

Last Price:
27.00
Seasonality Move:
8.49%
Buy
54

CNCR
Range Cancer Therapeutics ETF

Last Price:
14.00
Seasonality Move:
2.55%
Sell
45
Virtus LifeSci Biotech Clinical Trls ETF (BBC) is a Sell

Is Virtus LifeSci Biotech Clinical Trls ETF a Buy, Sell or Hold?

  • The current Virtus LifeSci Biotech Clinical Trls ETF [BBC] share price is $27.70. The Score for BBC is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
  • BBC is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
54
Range Cancer Therapeutics ETF (CNCR) is a Buy

Is Range Cancer Therapeutics ETF a Buy, Sell or Hold?

  • The current Range Cancer Therapeutics ETF [CNCR] share price is $14.19. The Score for CNCR is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
  • CNCR is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

BBC Stock Price Chart

What is Virtus LifeSci Biotech Clinical Trls ETF's stock price today?

  • The Virtus LifeSci Biotech Clinical Trls ETF share price today is $27.70
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BBC is experiencing buying pressure, which is a positive indicator for future bullish movement.

CNCR Stock Price Chart

What is Range Cancer Therapeutics ETF's stock price today?

  • The Range Cancer Therapeutics ETF share price today is $14.19
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CNCR is experiencing buying pressure, which is a positive indicator for future bullish movement.

BBC Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.59 Sell
Relative Strength Index (14 RSI): 46.44 Sell
Chaikin Money Flow: 1036 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (26.97 - 30.17) Sell
Bollinger Bands (100): (26.86 - 29.48) Sell

CNCR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.35 Sell
Relative Strength Index (14 RSI): 47.36 Sell
Chaikin Money Flow: 4099 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (13.71 - 15.35) Sell
Bollinger Bands (100): (14.11 - 15.45) Sell

BBC Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 26.72 Buy
20-day SMA: 28.37 Sell
50-day SMA: 28.59 Sell
200-day SMA: 27.79 Sell
8-day EMA: 27.29 Buy
20-day EMA: 27.94 Sell
50-day EMA: 28.29 Sell
200-day EMA: 27.25 Buy

CNCR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 13.6 Buy
20-day SMA: 14.43 Sell
50-day SMA: 14.76 Sell
200-day SMA: 15.02 Sell
8-day EMA: 13.87 Buy
20-day EMA: 14.22 Sell
50-day EMA: 14.57 Sell
200-day EMA: 14.54 Sell

Virtus LifeSci Biotech Clinical Trls ETF Earnings Growth & BBC Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Range Cancer Therapeutics ETF Earnings Growth & CNCR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Virtus LifeSci Biotech Clinical Trls ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Range Cancer Therapeutics ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):